GKOS vs. PHG, ZBH, SOLV, SNN, PEN, STVN, BLCO, INSP, NARI, and PRCT
Should you be buying Glaukos stock or one of its competitors? The main competitors of Glaukos include Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.
Glaukos vs.
Koninklijke Philips (NYSE:PHG) and Glaukos (NYSE:GKOS) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations, community ranking, dividends and media sentiment.
Koninklijke Philips has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Glaukos has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500.
Glaukos has a consensus price target of $147.75, suggesting a potential downside of 5.65%. Given Glaukos' stronger consensus rating and higher possible upside, analysts plainly believe Glaukos is more favorable than Koninklijke Philips.
13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 99.0% of Glaukos shares are held by institutional investors. 6.4% of Glaukos shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Koninklijke Philips has a net margin of -1.83% compared to Glaukos' net margin of -42.43%. Koninklijke Philips' return on equity of 10.11% beat Glaukos' return on equity.
Glaukos received 71 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 64.83% of users gave Glaukos an outperform vote while only 56.56% of users gave Koninklijke Philips an outperform vote.
In the previous week, Glaukos had 2 more articles in the media than Koninklijke Philips. MarketBeat recorded 8 mentions for Glaukos and 6 mentions for Koninklijke Philips. Glaukos' average media sentiment score of 0.71 beat Koninklijke Philips' score of 0.24 indicating that Glaukos is being referred to more favorably in the news media.
Glaukos has lower revenue, but higher earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Glaukos, indicating that it is currently the more affordable of the two stocks.
Summary
Glaukos beats Koninklijke Philips on 14 of the 19 factors compared between the two stocks.
Get Glaukos News Delivered to You Automatically
Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NYSE:GKOS) was last updated on 1/20/2025 by MarketBeat.com Staff
Free GKOS Stock Alerts